Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewed
HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma.
Juan Yuan, Subhamita Maitra, Eirini Antoniou…·Johan Holmberg
This paper shows that HIF2α reduces MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma, suggesting HIF2 has tumor suppressor rather than oncogenic function.
1 citation